4//SEC Filing
Shanmugam Muthusamy 4
Accession 0001870913-25-000002
CIK 0001023024other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 8:19 PM ET
Size
8.6 KB
Accession
0001870913-25-000002
Insider Transaction Report
Form 4
Shanmugam Muthusamy
DirectorHEAD OF R&D, COO-NOVITIUM OPS
Transactions
- Award
Common Stock
2025-02-12+14,362→ 83,014 total - Award
Common Stock
2025-02-12+9,574→ 92,588 total
Holdings
- 632,620(indirect: By LLC)
Common Stock
- 5,000(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025.
- [F2]These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting.
- [F3]The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- [F4]The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001870913
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 8:19 PM ET
- Size
- 8.6 KB